| Bristol-Myers Squibb SA - REVLIMID 10 mg, Hartkapseln | | 57712 | | 02 | | REVLIMID 10 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 29.08.2007 | | |
| | Composition | | lenalidomidum 10 mg, lactosum 294 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.8 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, E 172 (flavum), Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Lenalidomidum | 10 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lenalidomidum | 10 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | 294 mg | | | | | | | | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 21 Gélule(s) | 2482.70 | 2609.50 | A | LS | Non |
|
|
